WOCKHARDT | PROCTER & GAMBLE HEALTH | WOCKHARDT/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -15.8 | 34.5 | - | View Chart |
P/BV | x | 2.5 | 10.5 | 24.0% | View Chart |
Dividend Yield | % | 0.0 | 2.0 | - |
WOCKHARDT PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WOCKHARDT Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
WOCKHARDT/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 316 | 5,366 | 5.9% | |
Low | Rs | 145 | 3,883 | 3.7% | |
Sales per share (Unadj.) | Rs | 184.0 | 740.7 | 24.8% | |
Earnings per share (Unadj.) | Rs | -43.1 | 138.2 | -31.2% | |
Cash flow per share (Unadj.) | Rs | -25.7 | 155.2 | -16.5% | |
Dividends per share (Unadj.) | Rs | 0 | 95.00 | 0.0% | |
Avg Dividend yield | % | 0 | 2.1 | 0.0% | |
Book value per share (Unadj.) | Rs | 231.7 | 447.6 | 51.8% | |
Shares outstanding (eoy) | m | 144.09 | 16.60 | 868.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.3 | 6.2 | 20.1% | |
Avg P/E ratio | x | -5.3 | 33.5 | -16.0% | |
P/CF ratio (eoy) | x | -9.0 | 29.8 | -30.1% | |
Price / Book Value ratio | x | 1.0 | 10.3 | 9.6% | |
Dividend payout | % | 0 | 68.7 | -0.0% | |
Avg Mkt Cap | Rs m | 33,202 | 76,761 | 43.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6,370 | 2,062 | 309.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 26,510 | 12,296 | 215.6% | |
Other income | Rs m | 1,220 | 184 | 663.4% | |
Total revenues | Rs m | 27,730 | 12,480 | 222.2% | |
Gross profit | Rs m | -1,930 | 3,247 | -59.4% | |
Depreciation | Rs m | 2,510 | 281 | 893.2% | |
Interest | Rs m | 3,020 | 8 | 39,220.8% | |
Profit before tax | Rs m | -6,240 | 3,142 | -198.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -30 | 847 | -3.5% | |
Profit after tax | Rs m | -6,210 | 2,295 | -270.6% | |
Gross profit margin | % | -7.3 | 26.4 | -27.6% | |
Effective tax rate | % | 0.5 | 27.0 | 1.8% | |
Net profit margin | % | -23.4 | 18.7 | -125.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 19,140 | 11,713 | 163.4% | |
Current liabilities | Rs m | 34,350 | 6,791 | 505.8% | |
Net working cap to sales | % | -57.4 | 40.0 | -143.3% | |
Current ratio | x | 0.6 | 1.7 | 32.3% | |
Inventory Days | Days | 39 | 263 | 15.0% | |
Debtors Days | Days | 11 | 343 | 3.2% | |
Net fixed assets | Rs m | 48,670 | 10,617 | 458.4% | |
Share capital | Rs m | 720 | 166 | 433.7% | |
"Free" reserves | Rs m | 32,660 | 7,265 | 449.6% | |
Net worth | Rs m | 33,380 | 7,431 | 449.2% | |
Long term debt | Rs m | 2,240 | 0 | - | |
Total assets | Rs m | 70,750 | 22,330 | 316.8% | |
Interest coverage | x | -1.1 | 409.1 | -0.3% | |
Debt to equity ratio | x | 0.1 | 0 | - | |
Sales to assets ratio | x | 0.4 | 0.6 | 68.0% | |
Return on assets | % | -4.5 | 10.3 | -43.7% | |
Return on equity | % | -18.6 | 30.9 | -60.2% | |
Return on capital | % | -9.0 | 42.4 | -21.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 3.5 | 13.1 | 26.6% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 920 | 1,605 | 57.3% | |
Fx inflow | Rs m | 730 | 1,465 | 49.8% | |
Fx outflow | Rs m | 920 | 1,605 | 57.3% | |
Net fx | Rs m | -190 | -140 | 135.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,530 | 2,360 | 64.8% | |
From Investments | Rs m | -1,250 | -215 | 581.4% | |
From Financial Activity | Rs m | -3,150 | -985 | 319.9% | |
Net Cashflow | Rs m | -2,800 | 1,160 | -241.3% |
Indian Promoters | % | 54.9 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 51.8 | - | |
Indian inst/Mut Fund | % | 4.5 | 20.3 | 22.1% | |
FIIs | % | 4.2 | 7.6 | 54.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 45.1 | 48.2 | 93.5% | |
Shareholders | 161,813 | 56,730 | 285.2% | ||
Pledged promoter(s) holding | % | 74.5 | 0.0 | - |
Compare WOCKHARDT With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Wockhardt | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 4.99% | -0.55% | 1.18% |
1-Month | 0.15% | -7.47% | -0.75% |
1-Year | 290.07% | -3.02% | 61.82% |
3-Year CAGR | 13.79% | -9.12% | 18.16% |
5-Year CAGR | 7.92% | 5.75% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Wockhardt share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of Wockhardt hold a 54.9% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of Wockhardt, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.